#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune haemolytic anaemia Cholestatic pruritus Fabry's disease Nodal marginal zone B-cell lymphoma Leukodystrophy Chondrosarcoma Ichthyosis Retinitis pigmentosa Pericarditis Obesity Prolymphocytic leukaemia Intracranial calcification Thrombocytosis Hyperchylomicronaemia Acute graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent Sarcoma Hepatic angiosarcoma – Life with Disease Hypereosinophilic syndrome – Diagnostics Congenital nephrogenic diabetes insipidus – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information Mantle cell lymphoma refractory Progressive multifocal leukoencephalopathy – Diagnostics Anaplastic thyroid cancer – Treatment Myelodysplastic syndrome with excess blasts – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Danicamtiv L-PROLINE Istem-01 Ulotaront Fentanyl Citrate ALKYLATING AGENTS Gliquidone Quetiapine Bms-986449-03 Df6002 Ecoo1A Hydroxocobalamin Interferon Beta-1A Febuxostat Sodium Hypochlorite Rp1 Moxifloxacin Ipilimumab Tipapkinogene Sovacivec Bleomycin More therapies…

    Learn about Your Condition

    Thyroidectomy Depression Metastases to lymph nodes Subdural haematoma Persistent depressive disorder Caesarean section Pancreatic neoplasm Chronic granulomatous disease Anaplastic thyroid cancer Bile acid synthesis disorder Facial paresis Hyperparathyroidism secondary Death neonatal Fibromyalgia Skin ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on the Use of Florbetaben (18F) PET Imaging for Diagnosing Cardiac AL Amyloidosis in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Florbetaben (18F)
    Germany Spain

  • Study on [68Ga]Ga-PentixaFor for Detecting Multiple Myeloma in Patients Under 66 Eligible for Stem Cell Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Adrenaline Tartrate Ph. Eur.
    • Anhydrous Caffeine
    • Paracetamol Dc
    France

  • Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour of the lung
    Investigated Drugs:
    • Satoreotide Trizoxetan Gallium Ga-68
    Denmark

  • Study on Fluorescence-Guided Surgery for Colorectal Liver Metastases Using SGM-101 and Indocyanine Green for Patients with Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to liver
    Investigated Drugs:
    • Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
    The Netherlands

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    • Neuropathy peripheral
    Investigated Drugs:
    • Gadoquatrane
    • Gadoteridol
    • Gadoteric Acid
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study on Pulmonary Embolism: Comparing Iomeprol Dosages in CT Scans for Patients with Suspected Pulmonary Embolism

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Iomeprol
    Spain
Previous Page
1 … 20 21 22

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!